IFNG and neoplasm: Co-administration of decitabine with Cy/GVAX inhibited tumor growth and was associated with enhanced interferon gamma production both in splenocytes and tumor infiltrating lymphocytes (TILs), while decitabine administration after Cy/GVAX resulted in increased tumor growth, likely through inhibition of the immune response[22].